Search clinical trials for: NI-03

Total 125 results

Kangen Pharmaceuticals, Inc

Completed

A Dose Ranging Study Evaluating Efficacy and Safety of NI-03 (Tactic)

Chronic Pancreatitis

United States, Russian Federation, Ukraine
HealOr

Completed

Wound Healing Effects of HO/03/03 In Patients With Diabetic Neuropathic Plantar and Venous Ulcers, Pilot Study.

Diabetic Foot Ulcer | Venous Ulcer

Israel
HealOr
Cato Research; Clinigene International Ltd

Unknown

Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers (Truheal)

Diabetic Foot Ulcer

United States, India
HealOr

Unknown

Safety and Efficacy Study of HO/03/03 10-40 Micro Grams to Treat Hard to Heal Wounds (H2H)

Hard to Heal Wounds

Israel
Light Chain Bioscience - Novimmune SA

Completed

NI-0401 in Patients With Acute Renal Allograft Rejection

Acute Renal Transplant Rejection

France
Light Chain Bioscience - Novimmune SA

Completed

First in Human Study of NI-0701 in Healthy Volunteers

Healthy Volunteers

United Kingdom
Changhua Christian Hospital

Terminated

Simultaneously Using Traditional Chinese Medicine (Si-Ni-Tang) to Treat Septic Shock Patients

Septic Shock

Taiwan
Anhui Provincial Hospital

Not yet recruiting

The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia

B Lymphoblastic Leukemia/Lymphoma

China
Swedish Orphan Biovitrum

Completed

A Study to Evaluate Emapalumab in Japanese Healthy Volunteers.

Rare Diseases

Japan
Guangdong Provincial Hospital of Traditional Chinese...

Completed

The Efficacy of Si-Ni-Tang (a Chinese Herbal Formula) for Severe Sepsis

Severe Sepsis

China
University of Ulster
University College Cork; Dublin City University; Northern Ireland Chest Heart...

Not yet recruiting

The Youth - Physical Activity Towards Health Intervention in Northern Ireland (Y-PATH NI)

Physical Inactivity
Hôpital NOVO

Recruiting

Efficacy of Non-instrumental Pleural Chest Physiotherapy (KINEPANCH)

Infectious Pleural Effusion

France
Light Chain Bioscience - Novimmune SA

Recruiting

A Study of NI-1801 in Patients With Mesothelin Expressing Solid Cancers

Triple Negative Breast Cancer | Epithelial Ovarian Cancer | Non-squamous Non-small-cell Lung Cancer

Italy, France
Tarsus Pharmaceuticals, Inc.

Completed

Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis (Saturn-2)

Blepharitis

United States
Cosmo Technologies Ltd

Recruiting

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

Advanced Refractory Solid Tumors | Subjects Considered Likely to Respond to CB-03-10

United States
Light Chain Bioscience - Novimmune SA

Completed

Study of an Anti-TLR4 mAb in Rheumatoid Arthritis

Rheumatoid Arthritis

Serbia, Bosnia and Herzegovina, Bulgaria, Georgia, Hungary, Moldova, Republic of, Poland
University of Vienna
Medical University of Vienna; Flinders University; Queensland University of Technology and other collaborators

Completed

Dietary Nitrate, Vascular Function and Inflammation

Inflammation | Hypertension

Austria
Enterin Inc.

Recruiting

Study of Subcutaneously Administered ENT-03 for the Treatment of Obesity and Diabetes

Obesity | Diabetes Mellitus, Type 2

United States
1200 Pharma, LLC
Translational Research in Oncology

Recruiting

First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors

Advanced Solid Tumor

United States
Xgene Pharmaceutical Pty Ltd

Completed

Phase 1 XG005-03 Topical Study

Pain

Australia
Cellivery Therapeutics, Inc.
Labcorp Corporation of America Holdings, Inc

Suspended

iCP-NI - Safety, Tolerability, Pharmacokinetic, and Immunogenicity Study in Healthy Male and Female Subjects

Healthy Volunteers

United States
Balgrist University Hospital

Completed

Evaluation of the Intraoperative Accuracy of 3D-planned and Guided Osteotomies of the Hand and Forearm (CARDFOREARM)

Posttraumatic or Congenital Bone Deformity

Switzerland
Swedish Orphan Biovitrum

Completed

First in Human Study of an Anti-IFN Gamma Monoclonal Antibody in Healthy Volunteers

Healthy Volunteers

United Kingdom
Tarsus Pharmaceuticals, Inc.

Completed

Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD (Ersa)

Meibomian Gland Dysfunction | Blepharitis | Demodex Infestation

United States
Light Chain Bioscience - Novimmune SA

Terminated

Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody (PIANO)

Primary Biliary Cirrhosis

Italy, United Kingdom
Light Chain Bioscience - Novimmune SA

Completed

NI-0801 in Allergic Contact Dermatitis

Allergic Contact Dermatitis
HenKan Pharmaceutical Co., Ltd.

Completed

Comparison Study With E-DO in Chronic Hand Dermatitis

Chronic Hand Dermatitis

Taiwan
Tarsus Pharmaceuticals, Inc.

Completed

Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis (Saturn-1)

Blepharitis

United States
Acceleron Pharma Inc. (a wholly owned subsidiary...

Terminated

Extension Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

Canada
Swedish Orphan Biovitrum

Recruiting

Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE (EMERALD)

Systemic Lupus Erythematosus | Macrophage Activation Syndrome | Still Disease | Secondary Hemophagocytic Lymphohistiocytosis | SJIA | AOSD | MAS

United States, Belgium, Italy, Netherlands, United Kingdom, China, France, Spain, Czechia, Canada, Sweden, Japan, Germany, Poland
Maastricht University Medical Center

Completed

NWT-03 and Brain Function

Cognition | Brain Vascular Function

Netherlands
Cerecin

Completed

Tricaprilin Phase 2 Pilot Study in Migraine

Migraine

Australia
Newtricious R&D BV
Maastricht University

Completed

NWT03 and Arterial Stiffness

Metabolic Syndrome

Netherlands
Newtricious R&D BV

Completed

Effect of NWT-03 on Blood Pressure

Blood Pressure | Albuminuria

Ireland
Cosmetique Active International

Not yet recruiting

Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins

Hyperpigmentation

Brazil
Shanghai Institute Of Biological Products
Fudan University

Completed

A Phase Ⅰa Clinical Study Exploring Efficacy of SIBP-03 When Treating the Patients With Advanced Malignant Solid Tumors.

Tumor

China
Swedish Orphan Biovitrum
Seventh Framework Programme

Completed

Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic Lymphohistiocytosis

Primary Haemophagocytic Lymphohistiocytosis

United States, Sweden, Spain, Italy, Germany, United Kingdom
Swedish Orphan Biovitrum
Seventh Framework Programme

Completed

A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody

Hemophagocytic Lymphohistiocytosis

United States, France, Italy, Spain, United Kingdom
Lung Therapeutics, Inc

Completed

Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult Subjects

Idiopathic Pulmonary Fibrosis

United Kingdom
Cerecin

Withdrawn

A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

Alzheimer's Disease
Newtricious R&D BV

Completed

Effect of NWT-03 on Blood Pressure - Part 1

Blood Pressure
Cosmetique Active International

Recruiting

Efficacy and Tolerability of Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins

Hyperpigmentation

Portugal
Swedish Orphan Biovitrum
Light Chain Bioscience - Novimmune SA

Terminated

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH

Hemophagocytic Lymphohistiocytoses

United States
TG Therapeutics, Inc.

Active, not recruiting

Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia

Follicular Lymphoma | Marginal Zone Lymphoma | DLBCL | CLL | MCL | Indolent Lymphoma | Richter's Transformation | SLL | Mediastinal Large B-cell Lymphoma | Aggressive Lymphoma

United States
Universidad Autonoma de Madrid

Completed

Biobehavioral Physical Therapy Strategies Based on Therapeutic Exercise Applied to Chronic Migraine Patients

Chronic Migraine | Chronic Headache

Spain
Intrepid Therapeutics, Inc.

Completed

A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris

Acne Vulgaris

United States
Fuda Cancer Hospital, Guangzhou
Shanghai Asclepius Meditech Co., Ltd

Completed

Hydrogen Gas for Cancer Rehabilitation

Adult Solid Tumor

China
Swedish Orphan Biovitrum
PRA Health Sciences; Cromsource; BioMérieux; Q2 Solutions; Cytel Inc.; ABF Pharmaceutical...

Terminated

Study to Investigate the Pharmacokinetics, Pharmacodynamics and Assess the Efficacy and Safety to Support Dose Selection of Emapalumab in Pre-empting Graft Failure in Patients at High Risk After HSCT.

Graft Failure

Canada, Australia, Israel
Dr. Reddy's Laboratories Limited

Completed

A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks

Acne Vulgaris

United States
NS Pharma, Inc.
Nippon Shinyaku Co., Ltd.

Not yet recruiting

NS-050/NCNP-03 in Boys With DMD (Meteor50)

Duchenne Muscular Dystrophy

United States

Search clinical trials for: NI-03

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations